The largest database of trusted experimental protocols

19 protocols using y 27632

1

OVA-induced Airway Hyperreactivity Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were randomly divided into three groups (n = 10 for each group): OVA group, animals received OVA aerosol using sensitization protocol; OVA+Y-27632 group, animals were subjected to inhalation of Rho-kinase inhibitor (1mM) (Y-27632, Apexbio, USA) 10 min before the eight last OVA exposures for 6 min; control group, animals only received saline aerosol as the same protocol used for OVA administration. In addition, there was an OVA+saline group in which animals received saline before OVA administrations similar to the protocol used for the application of Rho-kinase inhibitor in OVA+Y-27632 group.
Since changes in airway conductance and eosinophil infiltration reaches to the maximum in 72h following antigen exposure in Guiana pigs, we examined AHR and inflammation 72h after the last antigen challenge [31 (link)–33 (link)].
+ Open protocol
+ Expand
2

Spontaneously Hypertensive Rat Drug Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult (4 month-old) male spontaneously hypertensive rats (SHR) and normotensive control Wistar-Kyoto (WKY) rats (Charles River Laboratories, San Diego, CA) were studied as described previously [10 (link)]. All animal procedures were performed in accordance with NIH guidelines (Guide for the Care and Use of Laboratory Animals, revised 2011) and protocols approved by the Institutional Animal Care and Use Committee of Loma Linda University. For in vivo drug treatments, Y-27632 (0.3 mg/kg/h, ApexBio Technology, TX), CCG-100602 (7.5 mg/kg/d, ApexBio Technology, TX) or vehicle control (DMSO, Sigma-Aldrich) were continuously administered for 2 weeks by Alzet osmotic minipumps (Model 2ML2, DURECT, CA), implanted subcutaneously in rats under anesthesia with 2% isoflurane (JD Medical, AZ) [10 (link)].
+ Open protocol
+ Expand
3

Hepatocyte Culture Optimization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat tail type I collagen, Transwell inserts (0.9 cm2 cell culture area, 1.6 × 106 pores/cm2), 12-well polystyrene tissue culture dishes, 12-well polycarbonate plates and Transwell inserts (1.12 cm2 cell culture area, 1.6 × 108 pores/cm2) were purchased from Corning (Corning, NY). SB202190 was from Selleckchem (Houston, TX). Collagenase (type IV) was purchased from Worthington Biochemicals (Lakewood, NJ). Y-27632 and N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) were purchased from ApexBio Technology (Houston, TX). Human collagen (type I) was obtained from Advanced Biomatrix (Carlsbad, CA). The ALP assay kit was from AbCam (Cambridge, MA). Gastrin was from Anaspec (Freemont, CA). UGT-Glo™ Assay and P450-Glo™ CYP3A4 Assay were obtained from Promega (Madison, WI). N-acetyl cysteine was purchased from MP Biomedicals (Santa Ana, CA). Murine EGF was procured from Peprotech (Rock Hill, NJ). Primocin was purchased from InvivoGen (San Diego, CA). Nicotinamide, L-alanine p-nitroanilide, fluorescein diacetate, loperamide, zafirlukast, cobalt chloride, potassium phosphate buffer, bovine serum albumin, and A83–01 were acquired from Sigma-Aldrich (St. Louis, MO). All other reagents and Bicinchoninic Acid (BCA) Protein Assay Kit were purchased from Thermo Fisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
4

RSV infection of A549 and primary nasal epithelial cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant wild-type RSV strain A2 in which enhanced GFP was inserted between the P and M genes was propagated, sucrose-purified, and titered by plaque assay on Vero cells, as previously described (Munir et al., 2008 (link)). The virus stock was sequenced and had no adventitious mutations, as confirmed by Sanger dideoxy sequencing. A549 cells were seeded and transfected with siRNA to MDA5, RIG-I, MAVS, or a nonsilencing negative control as described for HRV infections. Alternatively, primary nasal epithelial cells were digested from feeder cells and seeded in 12-well plates at 150,000 cells per well in 1 ml epithelial culture medium (Promocell) with 10 µM Y-27632 (ApexBio) and incubated at 37°C in 5% CO2. The cells were seeded on plates previously coated with 300 µl rat tail collagen (BD) at 30 µg/ml in PBS for 45 min at room temperature, washed twice with PBS, and air dried for 20 min. 36 h later, the cells were washed once with PBS. Transfected A549 cells or primary nasal epithelial cells were infected with RSV-GFP at an MOI of 1 or 0.2, respectively (diluted in appropriate complete medium, 300 µl per 12-well), for 1 h at room temperature, and washed twice with PBS to remove unadsorbed virus, and then medium was replaced (complete F-12K for A549; epithelial culture media without Y-27632 for nasal epithelial cells) and cultures were returned to 37°C in 5% humidified CO2.
+ Open protocol
+ Expand
5

Scalp Keratinocyte Isolation and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
In accordance with the Declaration of Helsinki Principles, ethical approval was
granted by the Institute of Ethical Committee of Nanfang Hospital, Southern
Medical School (approval number: NFEC-2021-265). HPKs were derived from the
scalp tissues of 20 to 30-year-old men or women after dermatoplasty. Personal
identity information was not obtained. To facilitate enzymatic lysis, the skin
was cut into pieces and incubated overnight in dispase II (Roche, Mannheim,
Germany) at 4°C. The next day, the epidermis was digested with 0.25%
trypsin-EDTA solution (Coolaber, China) for 20 min at 37°C, as previously
described.19 (link) The isolated keratinocytes were cultured in defined
keratinocyte-SFM (ScienCell, 2111, USA) plus 20 μM Y-27632 (APExBIO, B1293,
Houston, USA),20 and the medium was changed every 3 days.
+ Open protocol
+ Expand
6

hPSC Single-Cell Dissociation and FACS

Check if the same lab product or an alternative is used in the 5 most similar protocols
1 ml Accutase (Sigma, A6964) was added to each well of hPSC cultures in a 6-well plate and incubated at 37°C for 5-10 min, until cells detached. An equal volume of mTeSR Plus medium (StemCell Technologies, 100-0276) with 10 µM Y-27632 (APExBIO, B1293) was added to cells and cells were dissociated mechanically by pipetting with a P1000 pipette twice then centrifuged at 300 g for 5 min at 4°C. Excess medium was removed and cells were resuspended in fluorescence-activated cell sorting (FACS) buffer (1× PBS containing 2% BSA, 10 µM Y-27632 and 100 U/ml penicillin-streptomycin). Cells were passed through a 70 µm cell strainer, pre-coated with FACS buffer, and centrifuged at 300 g for 5 min at 4°C. Cells were resuspended in 1 ml FACS buffer and transferred to 5 ml FACS tubes (Corning, 352063). DAPI (0.2 µg/ml) was added to respective tubes. Flow cytometry was performed using a Bio Rad Ze5#3 and accompanying software.
+ Open protocol
+ Expand
7

Spontaneously Hypertensive Rat Drug Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult (4 month-old) male spontaneously hypertensive rats (SHR) and normotensive control Wistar-Kyoto (WKY) rats (Charles River Laboratories, San Diego, CA) were studied as described previously [10 (link)]. All animal procedures were performed in accordance with NIH guidelines (Guide for the Care and Use of Laboratory Animals, revised 2011) and protocols approved by the Institutional Animal Care and Use Committee of Loma Linda University. For in vivo drug treatments, Y-27632 (0.3 mg/kg/h, ApexBio Technology, TX), CCG-100602 (7.5 mg/kg/d, ApexBio Technology, TX) or vehicle control (DMSO, Sigma-Aldrich) were continuously administered for 2 weeks by Alzet osmotic minipumps (Model 2ML2, DURECT, CA), implanted subcutaneously in rats under anesthesia with 2% isoflurane (JD Medical, AZ) [10 (link)].
+ Open protocol
+ Expand
8

Characterization of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines (BT-20, T-47D, SK-BR-3, MCF-7, MDA-MB-468, MDA-MB-157, BT-474, DU4475, and MDA-MB-231) were all purchased from the American Type Culture Collection, Manassas, VA. An additional MCF-7 cell line derived from Dr. Jose Baselga’s laboratory (Memorial Sloan Kettering Cancer Center, New York, NY) was kindly provided by Dr. Yen-Shen Lu (National Taiwan University Hospital, Taipei, Taiwan) (14 (link)). Cell line authentication by short tandem repeat sequencing was performed to check for cross-contamination. BT-20 cells were grown in Eagle’s Minimum Essential Medium supplemented with 10% fetal bovine serum (FBS). MDA-MB-468 and MDA-MB-231 cells were grown in Leibovitz’s L-15 Medium supplemented with 10% FBS. All cells were maintained at 37°C in a 5% CO2 humidified atmosphere.
Cisplatin was purchased from Fresenius Kabi, Viman Nagar, India. Phthalic acid was obtained from Sigma-Aldrich, Merck KGaA, Darmstadt, Germany. For specific inhibitors, Y16 was obtained from MedChemExpress, Monmouth Junction, NJ; selisistat and olaparib from Selleck Chemicals, Houston, TX; NF340, Y27632, U73122, and ML7 from ApexBio Technology, Houston, TX.
+ Open protocol
+ Expand
9

Isolation and Quantification of Alveolar Type II Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Organoids were retrieved from Matrigel by mechanical dissociation with a P1000, washed 2× with 1 mL PBS and, resuspended with TrypLE and incubated at 37 °C until a single cell suspension was obtained with light pipetting (typically 10 min). Cells were washed 3× with 1 mL of FACS buffer consisting of PBS, 2% BSA and 10 µM Y-27632 (APExBIO, Cat#3008) and then filtered through a 30 µM mesh. Cells were stained for 1 h on ice in FACS buffer with a 1:60 dilution of anti HTII-280 IgM antibody. Cells were washed 3× with 1 mL of FACS buffer before 30 min of staining in FACS buffer with a 1:1000 dilution of anti-mouse IgM-Alexaflour-488 secondary antibody (Jackson Immunoresearch, Cat#715545140) on ice. After 3× washes with 1 mL of FACS buffer cells were suspended in FACS buffer with 1:4000 dilution of DAPI. Live cells (determined by exclusion of DAPI) positive for HTII-280 were identified by 488 emission intensity notably higher than primary only, secondary only controls and absence of 405 (DAPI) emission. All steps were carried out at 4 °C unless otherwise indicated. Cells were pelleted at 500xG for 5 min in swing bucket rotors. FACS was performed on either a Sony MA900 or the ThermoFisher Bigfoot Spectral Cell Sorter and analyzed in FlowJo v10.
+ Open protocol
+ Expand
10

Culture and Expansion of Human Bronchial Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Beas-2B immortalized human bronchial epithelial cells were obtained from American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium (Corning) with l-glutamine and 4.5 g/l glucose supplemented with 10% fetal bovine serum (VWR) and 1% penicillin/streptomycin (Corning). Deidentified primary human small airway epithelial cells (smAECs; <2 mm diameter) were obtained from the National Jewish Health Biobank and plated onto an irradiated National Institutes of Health (NIH)/3T3 (American Type Culture Collection) fibroblast feeder layer in F-medium containing 1 μM Y-27632 (APEX Bio). Upon visible colony formation (∼7–10 days), smAECs were removed with 0.25% trypsin (Corning), plated on tissue culture dishes double-coated with type I bovine collagen solution (Advanced Biomatrix), and grown to confluence in BronchiaLife Epithelial Medium supplemented with the complete LifeFactors Kit from Lifeline Cell Technology. All cells were maintained in 5% CO2 at 37 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!